SERPINB3 and neoplasm: In this setting, targeting both the reactive site loop of SerpinB3 and/or blocking its interaction with the LRP co-receptors could become novel therapeutic strategies which can control not only tumour cell growth and spreading, but also the restoration of effective immune surveillance within the tumoral microenvironment.